Targeting Epstein–Barr virus is a viable therapeutic strategy in multiple sclerosis: Commentary

Multiple Sclerosis Journal 2026 Open access

Read full text
Authors: Anna Karin Hedström
DOI: 10.1177/13524585251409951
Cited by: 0
References: 5

Fields of Study & Subjects

Multiple Sclerosis Research Studies Viral-associated cancers and disorders Cytomegalovirus and herpesvirus research

Publication details

Journal / source
Multiple Sclerosis Journal
Volume
32
Issue
4
Pages
363–364
Publication date
14 January 2026
Language
EN